Antipsychotic-Related Risks of Type 2 Diabetes Mellitus in Enrollees With Schizophrenia in the National Basic Public Health Service Program in Hunan Province, China
Ouyang F, He J, Cheng X, Zhou W, Xiao S, Fang J. Antipsychotic-Related Risks of Type 2 Diabetes Mellitus in Enrollees With Schizophrenia in the National Basic Public Health Service Program in Hunan Province, China. Frontiers In Psychiatry 2022, 13: 754775. PMID: 35280179, PMCID: PMC8909132, DOI: 10.3389/fpsyt.2022.754775.Peer-Reviewed Original ResearchAntipsychotic usePatients’ baseline body mass index.Public Health Service ProgramType 2 diabetes mellitusMental health officersAntipsychotic monotherapyRisk of T2DMSchizophreniaAntipsychoticsProportion of animal productsCumulative person-yearsBaseline fasting plasma glucose levelsHazard ratioClozapineRisperidoneRisk of type 2 diabetes mellitusFasting plasma glucose levelsT2DM riskBaseline body mass indexDiabetes-free patientsPerphenazineHealth service programsDevelopment of type 2 diabetes mellitusChlorpromazineHigher risk of T2DM